• Named among Lawdragon’s “500 Leading Litigators in America,” 2025-2026
• Recognized as one of the top securities litigators in the U.S. in the 2007-2025 editions of Chambers USA
• Honored as a "BTI Client Service All-Star" for 2016
• Selected for inclusion in Northern California Super Lawyers in 2005-2020
• Featured in the 2006-2020 editions of Best Lawyers in America
• Named one of the nation's "Top 10 Commercial Litigation Lawyers" by U.S. Lawyer Rankings in 2007-2011 and 2014-2015

Current and Recent Matters

• Represent Dropbox in securities class actions in state and federal courts arising out of its IPO.  The federal court granted defendants’ motion to dismiss.  The state court granted defendants’ motion to dismiss based on Dropbox’s federal forum provision.  The California Court of Appeals affirmed the dismissal. The California Supreme Court denied plaintiff's petition for review.
• Represented MacroGenics in a securities class action filed following announcement of clinical trial results. The court granted defendants’ first motion to dismiss with prejudice. The Fourth Circuit Court of Appeals affirmed the dismissal.
• Represent Viatris in a securities class action alleging false and misleading statements regarding its biosimilar business and financial projections. The court granted defendants’ first motion to dismiss with prejudice. 
• Represented Invuity in a securities class action arising out of missed quarterly guidance. The court granted defendants’ motion to dismiss with prejudice. 
• Represented Nutanix in a securities class action arising out of announcement of quarterly guidance. The court granted defendants’ motion to dismiss with prejudice with respect to most of the challenged statements. The action was settled.

• Represent Mesa Air in securities class actions in federal court arising out of its IPO.  The federal court granted defendants’ motion to dismiss with respect to most of the challenged statements. The action was settled.

• Represented A10 Networks in a securities class action arising out of a financial restatement. The court granted the motion to dismiss with leave to amend; plaintiffs appealed that decision and subsequently withdrew the appeal.
• Represent Mylan Pharmaceuticals in a securities class action arising out of an announcement of receipt of Form 483s and implementation of remediation program at a manufacturing plant.
• Represented Intrexon in a securities class action filed following publication of short seller report. The case was dismissed with leave to amend, which plaintiffs chose not to do.
• Represent Precigen in a securities class action arising out of announcement of SEC Cease and Desist Order relating to the company’s disclosures concerning its methane bioconversion platform. The court granted defendants' motion to dismiss as to most of the challenged statements. The action was settled.

• Represents the former Chairman of Intelsat S.A. in a securities class action arising out of allegations of insider trading. The court granted defendants' motion to dismiss in full and with prejudice. On appeal, a panel of the Ninth Circuit recently affirmed dismissal.

Derivative Actions

• Represented Nutanix and its officers and directors in a shareholder derivative suit related to the announcement of disappointing guidance. The action was dismissed with prejudice.
• Represented Zovio, (formerly Bridgepoint Education) and its officers and directors in a shareholder derivative suit related to an adverse regulatory development. The court dismissed the action with prejudice.
• Represented Zovio, (formerly Bridgepoint Education) and its officers and directors in a shareholder derivative lawsuit related to a self-tender offer. The action was dismissed with prejudice and the dismissal was affirmed by the U.S. Court of Appeals for the Ninth Circuit.
• Represented A10 Networks and its officers and directors in a shareholder derivative action arising from restatement of financials. Action was voluntarily dismissed following full briefing of motion to dismiss.

SEC and Internal Investigations

• Public networking communication company in SEC investigation regarding potential improper revenue recognition based on alleged contingent sales
• CFO of a public company regarding alleged insider trading in which the SEC declined to pursue charges after CFO received Wells Notice
• Public life sciences company in SEC investigation regarding potential improper revenue recognition based on alleged round-tripping of cash through related parties

• Public biotechnology company in SEC investigation regarding disclosure of clinical trial results.

• Public technology company in SEC investigation regarding stock sales by insiders.

• Audit Committee of a public company in internal investigation regarding potential violations of related party transaction disclosure rules
• Audit Committee of Ixia in internal investigation regarding accounting for multi-element transactions and post-contract support transactions
• Special Committee of Board of Directors of a public technology company in internal investigation regarding stock sales by several officers and directors
• Audit Committee of a public company in internal investigation regarding off-label promotion of FDA-approved medication

Clients in Other Representations Include

(* = multiple cases during different periods)

Technology Companies:

• A10 Networks, Inc.*
• Actel Corporation
• Agilent Technologies
• Allot Communications
• Alvarion
• Asante Technologies
• Avanex Corporation
• BackWeb Technologies Ltd.
• Brocade Communication Systems, Inc.*
• Capstone Turbine Corporation
• Catalyst Semiconductor
• chinadotcom Corporation
• Cobalt (Sun Microsystems, Inc.)
• Commerce One, Inc.
• Convergent Technologies
• CoSine Communications, Inc.
• Digital Impact, Inc.
• DigitalThink, Inc.
• Dropbox
• E.piphany, Inc.
• F5 Networks, Inc.
• Gadzoox Networks, Inc.
• Genesis Microchip
• i2 Technologies, Inc.*
• InterTrust Technologies Corp.
• Intraware, Inc.
• Juniper Networks*
• Liberate Technologies, Inc.
• Lipman Electronic Engineering
• Liquid Audio, Inc.
• Marketo, Inc.
• McAfee.com Corporation
• Merisel, Inc.
• Mindspeed Technologies, Inc.
• Mobility Electronics, Inc.
• New Focus, Inc.*
• Novell
• Nutanix
• OpenTV Corp.
• Palm, Inc.
• Peerless Systems Corporation
• Portal Software, Inc.
• QuickLogic Corporation
• Quovadx, Inc.
• RocketFuel
• Salesforce.com
• SeeBeyond
• Sirenza Microdevices, Inc.
• Software Publishing
• Sybase*
• Symyx Technologies, Inc.
• TIBCO Software Inc.
• Triton Network Systems, Inc.
• Tut Systems, Inc.
• VA Software Corporation
• Veritas Software Corporation
• Webvan Group Inc.

Life Sciences Companies:

• Antigenics
• Coherent, Inc.
• Guidant Corporation*
• Intrexon
• Invuity, Inc.
• Juno Therapeutics, Inc.
• MacroGenics, Inc.
• Mylan
• Pacific Biosciences
• Precigen

• Viatris Inc.

Other Companies:

• Bridgepoint Education, Inc.
• Critical Path, Inc.
• GSI Group, Inc.
• HealthpointCapital, LLC
• Landry's Seafood Restaurants
• Mesa Air Group, Inc.
• NortonLifeLock
• root9B Technologies, Inc.
• Strayer Education
• U.S. Auto Parts
• Universal Access

Select Publications

• Co-author, "2020 Life Sciences Securities Litigation Roundup," Wilson Sonsini Client Advisory, March 2021

• Co-author, "2019 Life Sciences Securities Litigation Roundup," Wilson Sonsini Client Advisory, April 2020

• Co-author with L. Smilan, "Carving Out Some IPO Protections," Corporate Board Member, January 2020
• Co-author, "2018 Life Sciences Securities Litigation Roundup," Wilson Sonsini Client Advisory, March 2019
• Co-author, "It's Long Past Time to Say So Long to State Court Securities Litigation,” Harvard Law School Forum on Corporate Governance and Financial Regulation, February 2019
• Co-author with P. Nielsen, "Ambiguity Deters Claims Pursuit: Practicalities May Make Section 304 More Trouble than Its Worth," San Francisco Daily Journal, August 2005

Select Speaking Engagements

• “Preventative Medicine for Biotech Boards: Lessons Learned from Life Sciences Securities Litigation,” ACC San Francisco Bay Area Chapter, Life Sciences 2021 – The Road Ahead, May 14, 2021
• Moderator, “Big Data, A.I., and the Evolving Role of Technology in Conducting Internal Investigations and Prosecuting and Defending Securities Fraud Cases,” Securities Enforcement Forum West, May 2020
• "Directors & Officers Liability:  Current Landscape and Proactive Strategies to Mitigate the Pressure on Increased Premiums and Retentions," MDMA Webinar, April 22, 2020
• Panelist, "The Current State of the D&O Market for IPOs," PLUS D&O Symposium, New York, New York, February 2020
• Panelist, "Avoiding Ethical Pitfalls During Internal Investigations," The Compliance Institute, ACC-New York City Chapter, Fordham Law School, New York, New York, September 2019
• Moderator, "Managing a True Corporate Crisis/Major Internal Investigation," Securities Enforcement Forum West, Palo Alto, CA, May 2017
• "A Guide to Venture-Backed Board Membership: Best Practices of Private Board Members," Rock Center for Corporate Governance, Stanford University, Palo Alto, CA, April 2017
• Moderator, "M&A Litigation and Claims Trends: Better, Worse or Just Different?" PLUS Conference, Chicago, IL, November 2016
• Faculty, "FCPA, SEC/DOJ Joint Actions, and Other Criminal Enforcement Trends," Securities Enforcement Forum West, San Francisco, CA, May 2016